Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.

Clinical trial NCT05798481 · COMPLETED

Trial details

NCT number: NCT05798481
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hypertension Cardiovascular Diseases

Start date: 2024-03-27
Primary completion: 2025-04-29
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.